RESPIRISCINT
LIVE

Serial Number

97149106

Owner

Cyclomedica Australia Pty Ltd

Attorney

Boris Umansky, Esq.

Filing Date

Nov 30, 2021

Add to watchlist:

No watchlists yet
View on USPTO

RESPIRISCINT Trademark

Serial Number: 97149106 • Registration: 7376907

RESPIRISCINT is a trademark filed by Cyclomedica Australia Pty Ltd on November 30, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Cyclomedica Australia Pty Ltd (9 trademarks)

New Illawarra Road
Lucas Heights NSW2234 , AU

Entity Type: 99

Trademark Details

Filing Date

November 30, 2021

Registration Date

May 7, 2024

Published for Opposition

November 7, 2023

Goods & Services

Crucibles for laboratory use; heat exchange crucibles for scientific use; scientific, research, weighing, measuring, detecting, testing, apparatus and instruments, namely, gas simulation apparatus in the nature of environmental test chambers

Chemical preparations and substances for medical purposes, diagnostic purposes, medical science, medical analysis purposes and medical imaging purposes, namely, gas mixtures for medical imaging use and diagnostic radiopharmaceutical preparations; diagnostic reagents for medical purposes; chemical reagents for medical purposes; pharmaceutical and veterinary preparations for the diagnosis and treatment of pneumological and oncological conditions; pharmaceutical and veterinary gas mixtures for the diagnosis and treatment of pneumological and oncological conditions; radioactive pharmaceutical preparations for medical diagnosis; radioactive pharmaceutical preparations for medical use

Precursors for medicines, namely, chemical precursors for use in the manufacture of radiopharmaceuticals used in diagnostic imaging in the field of nuclear medicine; precursors for pharmaceuticals, namely, chemical precursors for use in the manufacture of nuclear pharmaceuticals used in diagnostic imaging; chemical preparations for use in the pharmaceutical industry in the field of nuclear medicine; chemical products for use in the manufacture of radiopharmaceuticals for scientific purposes; chemical products for use in the manufacture of pharmaceuticals in the nature of radiopharmaceuticals

Surgical and medical apparatus and instruments for use in oncological surgery, nuclear medicine diagnostic imaging equipment and crucibles which are component parts of nuclear medicine diagnostic imaging equipment; medical analysis apparatus namely nuclear medicine diagnostic imaging equipment and crucibles which are component parts of nuclear medicine diagnostic imaging equipment; apparatus for medical diagnostic purposes namely nuclear medicine diagnostic imaging equipment and crucibles which are component parts of nuclear medicine diagnostic imaging equipment; medical diagnostic apparatus, namely, nuclear medicine diagnostic imaging equipment and crucibles which are component parts of nuclear medicine diagnostic imaging equipment; protective face masks for medical use; radiation shielding, namely, patient x-ray radiation shields

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 7, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
May 7, 2024 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Apr 2, 2024 DP1B
NOTICE OF ALLOWANCE CANCELLED
Apr 2, 2024 IUCN
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 2, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 7, 2023 NPUB
PUBLISHED FOR OPPOSITION
Nov 7, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 18, 2023 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Oct 3, 2023 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Sep 29, 2023 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 25, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 25, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 25, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 3, 2023 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 25, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 25, 2023 GNSL
SUSPENSION LETTER WRITTEN
Mar 25, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 15, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 14, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 14, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 14, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 14, 2022 GNRT
NON-FINAL ACTION WRITTEN
Sep 14, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 8, 2022 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 24, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 24, 2022 ECDR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 24, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 24, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 24, 2022 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 4, 2021 NWOS
NEW APPLICATION ENTERED
Dec 3, 2021 NWAP